The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

Author： Narod Steven  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.2, 2011-07, pp. : 581-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

By Poynter Jenny  

Cancer Causes and Control, Vol. 21, Iss. 6, 2010-06 ,pp. : 839-846

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite